Combinatorial synthesis of heterocycles: Solid phase synthesis of 2-arylquinoline-4-carboxylic acid derivatives

Tetrahedron Letters

Volumn 38, Issue 6, 1997, Pages 907-910

  Gopalsamy, Ariamala ^a,b   Pallai, Peter V ^a  

^a Procept Inc   (United States)

^b FMC CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVATIVE;

ARTICLE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; METHODOLOGY; REACTION ANALYSIS;

EID: 0031562030     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(96)02456-2     Document Type: Article

References (27)

1. 2. (a) Gallop, M.A.; Barrett, R.W.; Dower, W.J.; Fodor, S.P.A.; Gordon, E.M. J. Med. Chem.. 1994, 37, 1233-1251 and 1385-1401.
2. (b) Ellman, J.A.; Thompson, L.A. Chem. Rev. 1996, 96, 555-600.
3. (c) For recent reviews, see: Special Issue on Combinatorial Chemistry, Czarnik, A.W.; Ellman, J.A., Eds. Acc. Chem. Res, 1996, 29, 111-170.
4. 3. For reviews on peptide libraries, see: (a) Pinilla, C.; Appel, J.; Blondelle, S.; Dooley, C.; Dorner, B.; Eichler, J.; Ostresh, J.; Houghten, R.A. Biopolymers (Pept. Sci.) 1995, 37, 221-240.
5. (b) Pavia, M.R.; Sawyer, T.K.; Moos, W.H. BioMed. Chem. Lett. 1993, 3, 387-396.
6. 4. For some recent examples, see: (a) Johnson, C.R.; Zhang, B. Tetrahedron Lett. 1995, 36, 9253-9256.
7. (b) Valerio, R.M.; Bray, A.M.; Patsiouras, H. Tetrahedron Lett. 1996, 37, 3019-3022.
8. (c) Dinh, T.Q.; Armstrong, R.W. Tetrahedron Lett. 1996, 37, 1161-1164.
9. 5. (a) Marzinzik, A.L.; Felder, E.D. Tetrahedron Lett. 1996, 37, 1003-1006.
10. (b) Holmes, C.P.; Chinn, J.P.; Look, G.C.; Gordon, E.M.; Gallop, M.A. J. Org. Chem. 1995, 60, 7328-7333.
11. (c) Ruhland, B.; Bhandari, A.; Gordon, E.M.; Gallop, M.A. J. Am. Chem. Soc. 1996, 118, 253-254.
12. (d) Ruhland, T.; Kunzer, H. Tetrahedron Lett. 1996, 37, 2757-2760.
13. 6. (a) Mjalli, A.M.; Sarshar, S.; Baiga, J.T. Tetrahedron Lett. 1996, 37, 2943-2946.
14. (b) Wipf, P.; Cunningham, A. Tetrahedron Lett. 1995, 36, 7819-7822.
15. (c) Gordeev, M.F.; Patel, D.V.; Gordon, E.M. J. Org. Chem. 1996, 61, 924-928.
16. 7. Doebner, O. Ber. 1883, 16, 2357.
17. 8. (a) Lutz, R.E.; Bailey, P.S.; Clark, M.T.; Codington, J.F.; Deinet, A.J.; Freek, J.A.; Harnest, G.H.; Leake, N.H.; Martin, T.A.; Rowlett, R.J.; Salsbury, J.M.; Shearer, N.H.; Smith, J.D.; Wilson, J.W. J. Am. Chem. Soc. 1946, 68, 1813.
18. (b) Dabhi, T.P.; Sahah, V.H.; Parikh, A.R. J. Indian. Chem. Soc. 1993, 70, 597-9.
19. 9. (a) Farina, C.; Giardina, G.A.M.; Grugni, M.; Raveglia, L.F. International Patent WO 95/32948, 1995.
20. (b) Giardina, G.A.M.; Sarau, H.M.; Farina, C.; Medhurst, A.D.; Grugni, M.; Foley, J.J.; Raveglia, L.F.; Schmidt, D.B.; Rigolio, R.; Vassallo, M.; Vecchietti, V.; Hay, D.W.P. J. Med. Chem 1996, 39, 2281-2284.
21. 10. Kar, A. J. Pharm. Sci. 1983, 72, 1082-1084.
22. 11. Rink, H. Tetrahedron Lett. 1987, 28, 3787.
23. 12. Ottenheijm, H.C.J.; De Man, J.H.M. Synthesis, 1975, 163-164.
24. 1H NMR, MS (FAB) and HRMS in some cases.
25. 14. Method B: Method B was carried out analogously to method A, but using appropriate aldehyde 3 (0.45 mmol) and aniline 2 (0.45 mmol) instead of the benzylidine aniline 12.
26. 2O and 0.1% TFA (eluent A) to 60% of aqueous MeCN and 0.1% TFA (eluent B) over 35 min with a flow rate of 1 mL/min.
27. 16. Furka, A.; Sebestyen, F.; Asgedom, M.; Dibo, G. Int. J. Pept. Protein. Res. 1991, 37, 487.